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Abstract	  
 Bacterial resistance to antibiotics is a problem that has developed over the last 75 years 
due to over-prescribing and improper usage of these drugs.  Through these processes, bacteria 
have developed and spread the gene for an enzyme known as β-lactamase, which catalyzes the 
hydrolysis of the β-lactam ring in many penicillins, rendering them ineffective.  Accordingly, the 
purpose of this research is to create a sensing system to measure the hydrolysis of β-lactam 
antibiotics using the enzyme, β-lactamase.  To accomplish this, the gene for β-lactamase can be 
fused with the gene for a fluorescent protein known as enhanced green fluorescent protein 
(EGFP), which will decrease its fluorescence upon the local pH change generated by the 
catalysis of a β-lactam ring.  While previous research in this area has been successful in the 
development of an in vitro fusion of the genes encoding for β-lactamase and EGFP, present 
research is focused on separately incorporating the individual genes for EGFP and β-lactamase in 
pFLAG-MAC expression vectors to verify the local pH theory and to create an in vivo protein, 
thus creating a whole cell sensing system. 
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Introduction 
β-Lactam Antibiotics	  
The first	  β-lactam antibiotics to be classified in the modern era, penicillin, was discovered 
by Scotsman Alexander Fleming in 1928.  He noticed a bacteria free halo around a mold 
growing on a Staphylococcus culture, and he determined the bactericidal agent produced by the 
mold to be penicillin.  β-Lactam antibiotics are a class of antibiotics characterized by a β-lactam 
ring.  The β-lactam ring in penicillin, shown in Figure 1, is a four membered ring containing 
nitrogen, where the carbon atom adjacent to the nitrogen atom is a carbonyl carbon.  β-lactams 
work as efficient antibiotics without greatly affecting humans, because they target bacterial cell 
wall synthesis.  They interact with a bacterial protein called D-alanyl-D-alanine 
carboxypeptidase-transpeptidase, which is responsible for crosslinking peptidoglycan in bacterial 
cell walls.1  Without the crosslinking of peptidoglycan, the rigid cell walls unravel and the cells 
rupture, killing the bacteria and preventing replication.  These antibiotics are effective against 
both Gram-positive and Gram-negative bacteria in varying capacities.2 
 
 
 
 
 
Figure 1: Penicillin with the β-lactam ring encircled	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Bacteria of all kinds are either characterized as Gram-positive or Gram-negative, as seen 
in Figure 2, by using the Gram stain test.  The Gram stain	  first	  involves staining bacteria with 
crystal violet dye and then washing the dye off with ethanol.  Gram-positive bacteria will retain 
the violet color but Gram-negative bacteria will have the dye washed out.  A safranin counter 
stain will then be added to dye the Gram-negative bacteria pink, providing a contrast to 
differentiate the two.  Gram-positive bacteria have cell walls composed of secondary polymers 
like teichoic and teichuronic acids and a thick, multilayer peptidoglycan layer, no outer 
phospholipid membrane, and a high resistance to physical disruption from their environment.  In 
direct contrast, Gram-negative bacteria are shielded by a thin, single layer of peptidoglycan, do 
possess and outer membrane of lipopolysaccharide and protein, and have a low resistance to 
physical disruption from their environment.  Because of the additional outer membrane, Gram-
negative bacteria have a greater volume of periplasm in a well-defined periplasmic space than 
Gram-positive bacteria.3 
 
 
 
 
 
 
 
Figure 2: Comparison of Gram-positive and Gram-negative bacterial structures 
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Though both Gram-positive and Gram-negative bacteria are susceptible to β-lactam 
antibiotics, they interact with different types of these antibiotics in different ways.  β-Lactam 
antibiotics come in many forms and four different classes, penicillins, cephalosporins, 
monobactams, and carbapenems, as seen in Figure 3.  Perhaps the most well-known of these, 
penicillins, are commonly used to treat infection by Gram-positive bacteria of the Streptococci 
and Staphylococci genera, but they are used to treat infections from bacteria of the Clostridium 
and Listeria genera as well.  Penicillins are administered in unique forms through oral, 
intravenous, and intramuscular routes.4 
	   
 
  
 
 
 
 
 
 
Figure 3: The four classes of β-lactam antibiotics.   The β-lactam ring is highlighted in blue, the 
moieties characteristic to each β-lactam class highlighted is in red, and the R groups for each 
specific antibiotic are shown in black. 
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Currently, there are five generations of cephalosporins.  First-generation cephalosporins 
are primarily used to combat Gram-positive bacteria such as Streptococci and Staphylococci.  
However, more recent generations of cephalosporins tend to demonstrate greater activity against 
Gram-negative bacteria and less efficacy against Gram positive bacteria.5 
Carbapenems are useful because they generally have activity against a broader range of 
bacteria, including	  Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides as well as 
common Gram-positive bacteria, than more standard β-lactams like penicillins and 
cephalosporins.6  Carbapenems are frequently used to combat multidrug resistant bacteria and 
are often given to patients in hospitals, particularly in Intensive Care Units, when other 
antibiotics are found to be ineffective.  However, resistance to carbapenems is still a problem in 
healthcare settings.7 
Monobactams are a group of antibiotics characterized by a β-lactam ring that is not in 
conjunction with another ring structure; the only commercially available drug in this class is 
aztreonam.  While these antibiotics have been shown to be significantly less active than other β-
lactams against many bacteria, they have also been shown to be significantly more stable in the 
presence of β-lactamases produced by both Gram-negative and Gram-positive bacteria.  
However, monobactams have been shown to have increased activity against some Gram-negative 
organisms, especially Pseudomonas.  As such, searching for new monobactams could be in the 
future for the field of β-lactam research.8 
β-Lactamase and β-Lactamase Inhibitors 
β-Lactamase is a hydrolase produced by some bacteria to provide resistance to β-lactam 
antibiotics, seen in Figure 4.  These enzymes are used by bacteria to protect themselves by 
	  
	  
13 
	  
catalyzing the hydrolysis of the β-lactam ring, leaving the antibiotic completely ineffective as a 
bactericidal agent, as seen in Figure 5.2  The general characteristics of the mechanism of this 
hydrolysis reaction by β-lactamase have been outlined from a quantum mechanics approach.  
First, Glu-166 acts as a general base in the acylation step of the catalysis event, and Lys-73 
induces a hydrogen atom transfer (HAT) of a proton abstracted by Glu-166 via the Ser-130 
hydroxyl group to the nitrogen of the β-lactam ring.  The protonation of this nitrogen atom 
prompts an instantaneous opening of the β-lactam ring.9 
 
Figure 4: Model of the ribbon structure of β-lactamase 
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Figure 5: Cleavage of the β-lactam ring by β-lactamase 
The number of bacteria producing β-lactamase has increased dramatically in the last 
century since the discovery of penicillin.  Today, this is often attributed to antibiotics being 
overprescribed and the lack of completion of antibiotic regimens by patients.1  However, it is 
also believed that, as β-lactamases have always been present in some percentage, the 
introduction of antibiotics to modern medicine has greatly increased the speed of bacterial 
evolution in regard to this enzyme.  The ability to produce β-lactamase has become a highly 
favorable survival trait, so accordingly, it is seen more commonly today.2  
 In the face of the widespread abundance of β-lactamase producing bacteria, researchers 
have isolated and produced a series of β-lactamase inhibitors in an attempt to preserve β-lactam 
antibiotics as a valuable medicinal resource.  These β-lactamase inhibitors prevent the hydrolysis 
of the β-lactam ring, allowing these antibiotics to remain effective when used in conjunction with 
these inhibitors.2  Furthermore, these inhibitors can be classified into two different categories, 
reversible or irreversible inhibitors.  Reversible inhibitors, as the name suggests, do not 
inactivate enzymes like β-lactamase permanently.  Rather, the two sets of molecules exist with 
each other in a dynamic equilibrium as concentrations of either change or the inhibitor is 
β-Lactamase	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replaced with another molecule with higher affinity for the enzyme.  Some reversible inhibitors 
are actually just substrates that are slowly hydrolyzed by the enzymes.  Irreversible inhibitors, on 
the other hand, work towards a complete and permanent cessation of enzymatic activity for a 
particular enzyme.  These inhibitors can inactivate an enzyme by forming a covalent enzyme-
inhibitor complex10.  
Perhaps one of the most common of these combination drugs is known as AugmentinTM, 
which contains both amoxicillin and the β-lactamase inhibitor, clavulanic acid, as depicted in 
Figure 6.  Other β-lactamase inhibitors include sulbactam, which is commonly taken in 
combination with the antibiotic ampicillin, and tazobactam, which is frequently used in 
conjunction with the antibiotic piperacillin11.  All of these β-lactamase inhibitors work as 
irreversible inhibitors; they bind to β-lactamase and permanently inactivate it without ever 
releasing.  Furthermore, all three of these β-lactamase inhibitors also possess the same β-lactam 
ring that they prevent enzymatic cleavage of in β-lactam antibiotics, since competitive inhibitors 
bind to the same active site.	  
N
O
O
O
OH
OH
	  
Figure 6: Clavulanic acid 
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 Another use of β-lactamase is as a selectable marker.  Selectable markers are genes 
introduced into a cell that can, in a bacterial system, indicate the success of a transformation of 
DNA.  Commonly used in molecular biology as a selective marker, the gene for β-lactamase 
provides bacterial cells with the ability to grow on ampicillin containing agar.  Accordingly, any 
growth at all will serve as an indicator of the success of an uptake of a vector containing the 
gene, which then transfers the resistance to the bacteria. 
Green Fluorescent Protein 
 The photoprotein, green fluorescent protein, or GFP, can be used in laboratory settings as 
a reporter protein.  This protein, isolated from the jellyfish Aequorea victoria, can be seen in 
Figure 7.5  This protein is particularly useful in the lab setting because of its unique structure, 
which makes it is resistant to normal denaturing conditions, such as higher pH, higher salt 
content, or being in solution with organic solvents or detergents.  Other fluorescent proteins have 
been isolated from similar sources, like aequorin also from Aequorea victoria or other GFP 
variants from the sea pansy, Renilla reniformis.  However, though these molecules have identical 
chromophores, they do not have the advantage of GFP from Aequorea victoria of being 
autofluorescent.  No additional cofactors or substrates are needed to induce fluorescence in this 
molecule.12 GFP operates as an electron acceptor in a process known as Förster resonance energy 
transfer (FRET).  When undergoing FRET, the photoprotein bioluminescence excited (S1) state 
is coupled to the ground state (S0) of the GFP fluorophore within a protein-protein complex.  
GFP has been observed to undergo this process at micromolar concentrations.13 
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Figure 7: Aequorea victoria, the source of isolated GFP12 
GFP is comprised of 238 amino acid residues connected together in one polypeptide 
chain and is 27 kDa in size.14  This continuous polypeptide chain is folded into 11 β-sheets that 
are arranged in a barrel shape, known as both a β-barrel and a β-can.  This barrel structure is 
highly stable, and the only deviation from this cylindrical shape occurs in the form of side chain 
interactions between the seventh and eighth β-sheets.  This has also been shown to contribute to 
the high level of stability in this photoprotein by assisting in tertiary structure formation.  The 
ring of β-sheets encircles the chromophore region of GFP, which is contained in an axial helix 
that stretches across the inner region of the barrel, protecting it from denaturing conditions and 
preserving its ability to fluoresce.15  The chromophore is formed by a cyclic tripeptide of Ser-65-
Tyr-66-Gly-67, which has undergone post-translational modification as an imidazolone ring.14  
However, the β-barrel does not provide shielding against pH, and the pH sensitivity of the GFP 
chromophore, as well as the formation of the imidazolone ring, can be seen in Figure 8.  
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Cyclization is completed after the nitrogen of the glycine residue attacks the carbonyl carbon of 
the serine residue.  Afterward, the hydroxyl group of Tyr-66 residue is susceptible to 
deprotonation and reprotonation, affecting the ability of the photoprotein to fluoresce.14 
GFP has two major excitation peaks, one at 470 nm and the primary excitation peak of 
395 nm (λmax), and a primary emission peak at 508 nm.16  In order to optimize both the speed and 
intensity of the fluorescence of GFP, mutant forms of this protein have been created.  These 
include enhanced blue fluorescent protein (EBFP), enhanced yellow fluorescent protein (EYFP), 
and enhanced cyan fluorescent protein (ECFP), which all emit blue yellow, and cyan light 
respectively.  Others include GFPuv, which fluoresces at an intensity that is eighteen times 
brighter than wild type GFP from Aequorea victoria, and enhanced green fluorescent protein 
(EGFP).17 
 
Figure 8: Formation and pH sensitivity of the GFP chromophore14 
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Enhanced Green Fluorescent Protein 
The variant of GFP, EGFP, is the result of over 190 mutations and has similar properties 
to GFP, but it has a red shifted major excitation peak due to mutations at a couple of key amino 
acids near the GFP chromophore region, again comprised of the cyclic tripeptide of Ser-65-Tyr-
66-Gly-67, seen in Figure 9.  A red shift, or a bathochromic shift, occurs when an excitation or 
emission peak is changed from higher energy and shorter wavelengths to lower energy and 
longer wavelengths.  These mutations include the replacement of Phe-64 with Leu and of Ser-65 
with Thr.17  The fluorescence of EGFP, just as in some other GFP mutants, is pH dependent.  In 
more basic environments, the hydroxyl group of Tyr-66 in the chromophore region of EGFP is 
deprotonated, and the protein fluoresces intensely.  However, as pH decreases, this hydroxyl 
group is protonated and fluorescence is measurably decreased.  Furthermore, fluorescence of 
EGFP has been shown using fluorescence correlation spectroscopy (FCS) to flicker on a 45-300 
µs time scale as a result of proton exchange between the chromophore region and the buffer 
solution.18 
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Figure 9: Ribbon structure of EGFP showing its β-can structure protecting the cyclic tripeptide 
of the chromophore19 
It is EGFP, which has the red shifted λmax, seen in Figure 10, that is utilized in this 
research.20  Partially due to the fact EGFP has a maximum excitation shift towards longer 
wavelengths, EGFP has 35 times brighter fluorescence than GFP when excited at 488 nm.  This 
is beneficial because argon lasers emit light at 488 nm, and this particular wavelength is also 
common in most filter sets for a wide array of analytical instruments.17	  	  Accordingly, the 
fluorescence of EGFP can be measured and quantified using a spectrofluorometer, making EGFP 
useful as a reporter protein.21 
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Figure 10: Excitation and emission spectra of GFP and EGFP 
Existing research in this area has shown that it is possible to fuse the genes for EGFP and 
β-lactamase into a single protein for the monitoring of the hydrolysis mechanism.19  It is an 
essential factor of this research that the pH dependence of EGFP is preserved in this fusion 
protein so that a fluorescence change can still be observed.   This is seen in Figure 11, which 
shows a steady drop in the fluorescence of the fusion protein as pH changes from acidic to basic. 
Accordingly, a decrease in pH will cue a decrease in fluorescence at a range of wavelengths for 
both EGFP and the EGFP moiety of the fusion protein, including the maximum emission peak at 
509 nm. 
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Figure 11: Response of fluorescence to pH for the fusion protein of EGFP and β-lactamase19 
Ampicillin has been added to the presence of this fusion protein, and as was expected, the 
β-lactam ring was hydrolyzed by the β-lactamase portion of the molecule.  However, this 
degradation of the β-lactam ring releases a proton that results in a local pH change.  This 
decrease in pH was followed by a decrease in fluorescence due to the EGFP portion of the 
protein.19  The change in pH as a result of β-lactamase activity can be seen in Figure 12.  
Accordingly, the inactivation of ampicillin by β-lactamase can be quantified by monitoring the 
change in fluorescence over time.5 
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Figure 12: Change in fluorescence due to the hydrolysis of β-lactams 
Biosensors 
A biosensor is a chemical sensor that contains a biological component, which is used to 
determine the specific selectivity of the biosensor.  Furthermore,  biosensors are composed of a 
biological recognition element and a transducer working together.22  The first biosensor to be 
developed was the glucose enzyme electrode developed by Clark and Lyons in 1962.  This 
biosensor used an oxido-reductase enzyme called glucose oxidase and a platinum electrode to 
quantify the presence of glucose.  The enzyme was put in close proximity to the platinum anode, 
which was polarized at + 0.6 V, and reacted with its substrate, glucose.  The platinum anode 
responded to the peroxide produced by the enzymatic reaction by producing a quantifiable 
change in electrode potential, leading to the construction of sensing systems for the measurement 
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of glucose in blood plasma.23  This particular research will utilize a spectrofluorometer as the 
transducer. 
Perhaps one of the simplest examples of a biosensor that has been developed is known as 
the Bananatrode.  The Bananatrode is a biosensor comprised of a slice of banana pulp tissue 
placed on a gas permeable membrane and kept in place with a dialysis membrane, graphite 
powder, and liquid paraffin placed into an electrode cup to measure dopamine concentration.  If 
dopamine is in the presence of the Bananatrode, it will be oxidized from the oxygen in the air 
and subsequently reduced.  The reduction step generates a measureable current proportional to 
dopamine concentration.24  A biosensing system is an element of a biosensor, which does not 
have an onboard transducer, that detects the presence of an analyte in a sample.  A transducer is 
an element of a biosensor that produces a quantifiable signal that is proportional to the amount of 
a target analyte in a given sample.22 
Whole Cell Sensing Systems 
 A biosensing system is categorized as having either a molecular, cellular, or tissue 
sensing component.25  One of the purposes of this research is to create a cellular or whole cell 
sensing system, which has the advantage of remaining stable and highly selective across a wider 
range of temperatures and pH values, including physiological pH, when compared to the other 
systems.12  In comparison, a molecular based system requires the expense of isolating biological 
components without providing knowledge of how a particular analyte affects the cell as an entire 
system.26  However, one of the greatest hurdles of utilizing a whole cell sensing system is the 
loss of specificity that can be introduced as a result of unforeseen interference on the molecular 
level from other components of the cell.  These systems, which can be created from bacterial 
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sources like Escherichia coli, will respond to an environmental change, such as a pH change, and 
will produce a response.27  The genetic fusion of a reporter gene, such as the gene for β-
lactamase, to one of a biological recognition element, such as the gene for EGFP, can make this 
response visible and quantifiable.12   In this particular case, the quantifiable response is a 
measurable decrease in fluorescence.  These systems can be used to sense the presence of a vast 
array of analytes including metals, sugars, and many organic compounds.26   
It is the goal of this research to create such a whole cell sensing system to quantitatively 
measure the hydrolysis of β-lactam antibiotics.  This constructed sensing system will be used to 
find new β-lactamase inhibitors to be used in conjunction with existing β-lactam antibiotics.  
Once this system has been both generated and expressed, kinetic studies can be completed on it 
to allow for the monitoring of bioavailability of β-lactam antibiotics. 
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Materials and Methods 
Apparati 
Overnight cultures were grown on a VWR shaker table set to 200 rpm and 37 °C 
(Cornelius, OR).  Polymerase chain reaction (PCR) was performed in an Eppendorf Mastercycler 
Personal Thermocycler (Hamburg, Germany).  Gradient PCR was performed using a 9901 
Applied Biosystems Veriti 96-Well Fast Thermal Cycler manufactured by Thermo Fisher 
Scientific (Singapore). Gel electrophoresis was performed using a 1% agarose gel and 1x TAE 
buffer in an IBI Quickscreen QS-710 electrophoresis tank (New Haven, CT) connected to a 
Thermo EC105 power supply (Asheville, NC).  Gels were visualized using a UVP UV 
Transilluminator (Cornelius, OR) and a UVP BioDoc-It Imaging System (Upland, CA).  
Restriction digest reactions were completed in VWR Shel Lab 1211 water bath (Cornelius, OR).  
Gel slices were melted using a VWR Analog Heat Block (Cornelius, OR).  Bacterial cultures on 
plates were grown in a VWR Shel Lab 1500E incubator (Cornelius, OR).  Nucleic acid 
concentrations were determined using a ThermoScientific NanoDrop 2000C Spectrophotometer 
(Asheville, NC).  Sterilization of plastics and agar was executed using a 3870 Tuttnauer 
autoclave – steam sterilizer (Beit Shemesh, Israel).  Centrifugation steps were completed using a 
5404 Eppendorf AG Centrifuge (Hamburg, Germany).  Masses were obtained using a Mettler 
Toledo AL 54 analytical balance (Columbus, OH).  Stock cells were stored in a Thermo 
Scientific -80 °C freezer (Asheville, NC).   
Reagents 
Luria Bertani (LB) broth and LB agar were purchased from Difco (Lawrence, KS).  Taq 
PCR buffer, MgCl2, dNTP mix, Taq polymerase, HindIII, EcoRI, digestion buffer M, digestion 
buffer H, Blue Juice gel loading buffer, DH5α cells, and SOC media were purchased from 
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Invitrogen (Carlsbad, LA).  The Pfu Turbo polymerase was purchased from Agilent 
Technologies (Santa Clara, CA).  Ethidium bromide solution and ampicillin sodium were 
purchased from Sigma Aldrich (St. Louis, MO).  Agarose was purchased from IBI Scientific 
(Peosta, IA).  The 1 Kb DNA ladder was purchased from Phenix (Candler, NC).  DNA ligase 
and DNA ligase buffer were purchased from Promega (Madison, WI).  Primers were purchased 
from Eurofins MWG Operon (Huntsville, AL).  The pEGFP vector was donated by Leonidas 
Bachas (University of Kentucky, University of Miami) and the pFLAG-MAC vector was 
purchased from IBI Kodak (New Haven, CT).  Tris-acetate-ethylenediaminetetraacetic acid 
buffer (TAE buffer) (made one liter at 25x concentrated, then diluted to 1x with DI water) was 
prepared in the lab using tris base (121.0 g), glacial acetic acid (28.6 mL), and EDTA (18.6 g 
Na2EDTA) from EMD Chemicals (Gibbstown, NJ).  Miniprep, gel extraction, and Cycle Pure 
purification kits were purchased from Omega (Norcross, GA).  Miniprep and gel extraction kits 
were also purchased from QIAGEN (Valencia, CA). 
Overnight Cultures 
 Overnight cultures of the bacterial cells containing the plasmids pEGFP and pFLAG-
MAC were prepared from new stocks.  To 14 mL polypropylene BD Falcon tubes, 3 mL of LB 
broth with 100 µg/mL ampicillin was added.  To half of the tubes, a toothpick swirled through 
the new pEGFP stock from the -80 °C freezer was added.  To the other half of the tubes, a 
toothpick swirled through the new pFLAG-MAC stock from the -80 °C freezer was added.  This 
process was completed quickly to prevent the stocks from thawing and refreezing.  Each tube 
was capped but vented and placed on the shaker table overnight at 37 °C and at 200 rpm. 
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Miniprep (OMEGA Protocol) 
 In order to isolate the DNA from the pEGFP plasmid, an OMEGA Plasmid Mini Kit 1 
was used.  The LB broth containing the cultured bacterial cells was added to a 1.5 mL 
microcentrifuge tube and was pelleted by centrifugation at 10,000 x g for 1 minute in 1.5 mL 
increments.  Between centrifugation steps, the supernatant was decanted and disposed of so that 
the next 1.5 mL of culture could be added and pelleted.  The resulting pellet was resuspended by 
adding 250 µL of Solution 1, with RNase A added, and pipetting up and down to mix and 
disperse the cells.  To the same tube, 250 µL of Solution II was added to lyse the cells.  The 
microcentrifuge tube was gently inverted to form a clear lysate.  Within 5 minutes of this step, 
350 µL of Solution III was added to neutralize the solution and immediately inverted several 
more times.  At this point, a flocculent white precipitate could be observed.  The solution was 
centrifuged for ten minutes at 13,000 x g.  Concurrently, 100 µL of Equilibration Buffer was 
added to a HiBind DNA Mini Column to prepare it for the addition of the DNA.  This column 
was placed in the centrifuge at 13,000 x g for 1 minute and the flow through was discarded.  The 
supernatant, containing the DNA, was slowly aspirated to avoid disturbing the pelleted cellular 
debris and was transferred to the equilibrated column.  The column was placed back into the 
centrifuge at 13,000 x g for 1 minute.  The flow-through was discarded and the column was 
reused.  A volume of 500 µL of Buffer HB was added to the column, which was placed in the 
centrifuge at 13,000 x g for 1 minute.  The flow-through was discarded and the column was 
reused.  A volume of 700 µL of DNA Wash Buffer, diluted with absolute ethanol, was added to 
remove residual salts, and this was also placed in the centrifuge at 13,000 x g for 1 minute.  The 
flow-through was discarded and the column was reused.  The empty column was dried for 2 
minutes by centrifugation to remove all traces of ethanol.  The dry column was transferred to a 
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clean and sterile 1.5 mL microcentrifuge tube, and 30 µL of Elution Buffer was added.  This was 
allowed to sit for 2 minutes before the tube and column were placed back into the centrifuge for 
1 minute at 13,000 x g to elute the DNA.  The resulting miniprep was stored in the refrigerator. 
Miniprep (QIAGEN Protocol) 
Another protocol used to isolate the DNA from the pEGFP plasmid was the QIAGEN 
protocol which used the QIAprep® Spin Miniprep Kit.  The LB broth containing the cultured 
bacterial cells was added to a 1.5 mL microcentrifuge tube and was pelleted by centrifugation at 
10,000 rpm for 1 minute in 1.5 mL increments.  Between centrifugation steps, the supernatant 
was decanted and disposed of so that the next 1.5 mL of culture could be added and pelleted.  
The resulting pellet was resuspended by adding 250 µL of Buffer P1, with RNase A and 
LyseBlue reagent added, and pipetting up and down to mix and disperse the cells.  To the same 
tube, 250 µL of Buffer P2 was added to lyse the cells.  The microcentrifuge tube was gently 
inverted 4-6 times, and the solution turned blue.  Immediately, 350 µL of Buffer N3 was added 
and inverted 4-6 more times, turning the solution colorless. The solution was centrifuged for ten 
minutes at 13,000 rpm to form a compact white pellet.  The supernatant produced by this 
centrifugation step was applied to a QIAprep spin column by pipetting.  The column was placed 
back into the centrifuge at 13,000 rpm for 1 minute, and the flow-through was discarded and the 
column was reused.  A volume of 750 µL of Buffer PE, diluted with absolute ethanol, was added 
to the column, which was placed in the centrifuge at 13,000 x g for 1 minute.  The flow-through 
was discarded and the column was reused.  The empty column was dried for 1 minute by 
centrifugation to remove residual ethanol from the wash buffer.  The dry column was transferred 
to a clean and sterile 1.5 mL microcentrifuge tube, and 50 µL of Buffer EB (10 mM Tris⋅Cl, pH 
8.5) was added.  This was allowed to sit for 1 minute before the tube and column were placed 
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back into the centrifuge for 1 minute at 13,000 rpm to elute the DNA.  The resulting miniprep 
was stored in the refrigerator. 
Polymerase Chain Reaction (Taq Protocol) 
Polymerase Chain Reactions (PCRs) were conducted, with slight variations to determine 
optimum template DNA concentrations and temperatures by the following protocol.  The 
purpose of PCR was to isolate the individual genes for EGFP and β-lactamase, amplify them, 
and use specifically designed primers to incorporate unique restriction sites.  A diagram of the 
pEGFP plasmid from which both of these genes were isolated, with the cut sites visualized, can 
be seen in Figure 13. 
Figure 13: pEGFP plasmid showing the genes for EGFP and β-lactamase as well as the 
incorporation of unique restriction sites 
The contents of each tube for PCR were the same except for the addition of the respective 
forward and reverse primers for EGFP and β-Lactamase, which are shown in Table 1.  For both 
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genes, the HindIII restriction site is underlined in the forward primer and the EcoRI restriction 
site is underlined in the reverse primer. 
Table 1: Primers used in the PCR mixture 
 
β-Lactamase 
Forward Primer 5’-ACCACCGACGTAAAGCTTATG AGTATTCAACATTTCCGTCTG-3’ 
Reverse Primer 5’-GGCTGAGACTAATTCGTAAAC ATTGAATCCGTGGCACCACCA-3’ 
EGFP 
Forward Primer 5’-ACCACCGCAGTGAAGCTT ATGGTGAGCAAGGGCGAG-3’ 
Reverse Primer 5’-TACGTCCTCGACATGTTCATT GAATCCGTGACGCCACCA-3’ 
 
  After thawing all reactants, except Taq polymerase, 60 µL sterile distilled water was 
added to a PCR tube.  To this, 10 µL buffer (-MgCl2), 10 µL of EGFP or β-lactamase reverse 
primer (50 pmol/mL), 10 µL of EGFP or β-lactamase forward primer (50 pmol/mL), 4 µL DNA 
miniprep (pEGFP), 3 µL 50mM MgCl2, 2 µL dNTPs, and 1 µL Platinum Taq polymerase were 
added in this order, as depicted in Table 2.  Unlike some other polymerases, Taq polymerase 
needs MgCl2 to shift electron density from the α-phosphate of the incoming dNTP to aid in the 
nucleophilic attack of the hydroxyl group of the previously laid nucleotide.  In an attempt to 
increase DNA concentrations, 6 µL less of water (54 µL total) was used and 6 µL more of DNA 
miniprep (10 µL total) were used for some reactions.   
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Table 2: Components of PCR with Taq polymerase 
 
Reactant Volume (µL) 
Sterile Distilled Water 60 
Platinum Taq polymerase Buffer (-MgCl2) 10 
Reverse Primer 10 
Forward Primer 10 
EGFP DNA Miniprep 4 
MgCl2 3 
Deoxyribonucleoside triphosphate mix (dNTP) 2 
Platinum Taq polymerase 1 
Total 100 
 
These PCR tubes were transported to a thermocycler and were run under the following 
protocol (Table 3): denaturing at 94.0 °C for 1 minute, annealing at 67.0 °C for 1 minute, and 
extending at 72.0 °C for two minutes.  This cycle was repeated for a total of 50 cycles.  In an 
attempt to increase DNA concentrations, the annealing temperature was decreased to 65.0 °C for 
some reactions. 
Table 3: Thermocycler conditions for PCR with Taq polymerase 
 
 Temperature (°C) Time (min) 
Denaturing 94.0 1 
Annealing 67.0 1 
Extending 72.0 2 
50 Cycles 
 
Polymerase Chain Reaction (Pfu Turbo Protocol) 
When PCRs were conducted using the enzyme Pfu Turbo® DNA polymerase instead of 
Taq polymerase, the following protocol was used.   The contents of each tube were the same 
except for the addition of the respective forward and reverse primers for EGFP and β-Lactamase.  
After thawing all reactants, except Pfu Turbo, 2 µL DNA miniprep (pEGFP) was added to a PCR 
tube.  To this, 10 µL Pfu Turbo buffer, 1 µL dNTP mix, 1 µL Pfu Turbo, 10 µL of EGFP or β-
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lactamase reverse primer (50 pmol/mL), 10 µL of EGFP or β-lactamase forward primer (50 
pmol/mL), and 66 µL sterile distilled water were added in this order, as depicted in Table 4.  The 
polymerase Pfu Turbo does not need MgCl2 to function. 
Table 4: Components of PCR with Pfu Turbo 
 
Reactant Volume (µL) 
EGFP DNA Miniprep 2 
Pfu Turbo Buffer 10 
Deoxyribonucleoside triphosphate mix (dNTP) 1 
Pfu Turbo 1 
Reverse Primer 10 
Forward Primer 10 
Sterile Distilled Water 66 
Total 100 
 
These PCR tubes were transported to a thermocycler and were run under the following 
protocol (Table 5): denaturing at 94.0 °C for 1 minute, annealing at 50.0 °C for 1 minute, and 
extending at 72.0 °C for two minutes.  This cycle was repeated for a total of 30 cycles.  In an 
attempt to increase DNA concentrations, the annealing temperature was increased to 67.0 °C for 
some reactions, and for some reactions the number of cycles was increased to 50 for the same 
purpose. 
Table 5: Thermocycler conditions for PCR with Pfu Turbo 
 
 Temperature (°C) Time (min) 
Denaturing 94.0 1 
Annealing 50.0 1 
Extending 72.0 2 
30-50 Cycles 
 
Gradient PCR 
Gradient Polymerase Chain Reactions (Gradient PCRs) were conducted to amplify DNA 
at a wide range of annealing temperatures to optimize the reaction.  The contents of each tube, 
however, were the same except for the addition of the respective forward and reverse primers for 
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EGFP and β-Lactamase.  After thawing all reactants, except Taq polymerase, 24 µL sterile 
distilled water was added to a PCR tube.  To this, 4 µL buffer (-MgCl2), 4 µL of EGFP or β-
lactamase reverse primer (50 pmol/mL), 4 µL of EGFP or β-lactamase forward primer (50 
pmol/mL), 1.5 µL DNA miniprep (pEGFP), 1.2 µL 50mM MgCl2, 0.8 µL dNTPs, and 0.5 µL 
Platinum Taq polymerase were added in this order, as depicted in Table 6.  
Table 6: Components of Gradient PCR 
Reactant Volume (µL) 
Sterile Distilled Water 24 
Platinum Taq polymerase Buffer (-MgCl2) 4 
Reverse Primer 4 
Forward Primer 4 
EGFP DNA Miniprep 1.5 
MgCl2 1.2 
Deoxyribonucleoside triphosphate mix (dNTP) 0.8 
Platinum Taq polymerase 0.5 
Total 40 
 
These PCR tubes were transported to a gradient thermocycler and were run under the 
following protocol (Table 7): denaturing at 94.0 °C for 1 minute, annealing at 6 different 
temperatures of 50.0 °C, 54.0 °C, 58.0 °C, 62.0 °C, 66.0 °C, and 70.0 °C for 1 minute, and 
extending at 72.0 °C for one minute.  This cycle was repeated for a total of 50 cycles, and the 
reactants were held at 4 °C after completion. 
Table 7: Gradient thermocycler conditions for PCR 
 
 
 
 
PCR Product Purification through Gel Electrophoresis 
 The products of PCR were purified by separating the components through gel 
electrophoresis.  The agarose gel was prepared by adding approximately 0.5 g High Melting 
 Temperature (°C) Time (min) 
Denaturing 94.0 1 
Annealing 50.0, 54.0, 58.0, 62.0, 66.0, and 70.0 1 
Extending 72.0 1 
50 Cycles 
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Temp Agarose to a 125-mL Erlenmeyer flask with 50 mL 1X TAE Buffer.  The mixture was 
heated in the microwave for 1 minute and 3 µL of ethidium bromide was added so the DNA 
bands could be visualized later.  The contents of the flask were poured into the gel tray with the 
well comb added.  In order to produce larger slices of gel containing DNA, two sets of three tines 
on each well comb were taped together.  The gel was allowed to cool for 30 minutes until it 
solidified.  Next, the gel and its casting tray were immersed in 1X TAE Buffer in the 
electrophoresis tank.  A volume of 5 µL of Blue Juice Loading Buffer was added to and mixed 
into each PCR sample to load the DNA and visualize its progress through the gel.  The entire 
contents of each PCR tube (now ~105 µL) were added to each extra wide well.  To a third, 
normal width well, 5 µL of a 1 Kb DNA Ladder was added.  A potential of 100-110 volts was 
applied to the gel for 30 minutes.  At this point, DNA separation could be visualized using the 
UV transilluminator.  Using the DNA ladder, the desired DNA bands could be visualized for 
both EGFP and β-lactamase at ~800 bp.  These bands were excised using a sharp razor blade and 
were stored in the refrigerator for gel extraction. 
BioDoc-It Gel Imager 
 The BioDoc-ItTM Imaging System was used, alongside a standard camera, to image 
agarose gels after electrophoresis.  After turning on the instrument, the gel was placed inside the 
darkroom cabinet, the cabinet door was closed, and the UV transilluminator was activated.  It 
was verified that the overhead white light was deactivated, and the lens f-stop adjustment was 
rotated until the image was bright enough to observe on the LCD monitor.  Next, the zoom lens 
adjustment was rotated until the gel image was maximized in size, and the focus adjustment was 
rotated until clarity of the image was maximized.  Once the image is satisfactory, if the bands on 
the gel were dim, the “+” button on the touch pad was pressed to increase exposure time.  
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Conversely, if the bands were too bright, the f-stop adjustment can be rotated again.  The capture 
button was pressed, followed by the save button to save the image on the removable USB drive 
for later use. 
Gel Extraction (OMEGA) 
 Two different protocols were used to complete the gel extraction procedure, the OMEGA 
protocol and the QIAGEN protocol.  In the OMEGA protocol, the mass of the gel slice was 
determined by adding the gel to a microcentrifuge tube of pre-determined mass.  To this tube, 1 
volume of Binding Buffer was added, assuming a density of 1 g/mL.  The gel and binding buffer 
were incubated at approximately 60 °C for 7 minutes in a heating block until the gel was 
completely melted, vortexing every 2 minutes.  A HiBind Mini Column was inserted into a 2 mL 
collection tube, and up to 700 µL of melted gel was transferred to the Mini Column.  The column 
was placed in the centrifuge at 10,000 x g for 1 minute, and the resulting filtrate was discarded.  
At this point, if additional melted gel was to be added for a higher concentration of DNA, it 
would be pipetted in and placed back into the centrifuge under the same parameters.  An 
additional 300 µL of Binding Buffer was added into the column, which was placed back into the 
centrifuge at 13,000 x g for 1 minute.  The filtrate was discarded and the collection tube was 
reused.  A volume of 700 µL of SPW Wash Buffer, diluted with absolute ethanol, was added to 
remove residual salts and was placed into the centrifuge at 13,000 x g for 1 minute.  The filtrate 
was discarded and the column and collection tube were placed back into the centrifuge at 13,000 
x g for 2 minutes to completely dry the column.  The dry column was transferred to a clean, 
sterile 1.5 mL microcentrifuge tube and 30 µL of Elution Buffer was added and was allowed to 
sit for 2 minutes.  The DNA was eluted by centrifugation at 13,000 x g for 1 minute and the 
DNA was stored in the refrigerator. 
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Gel Extraction (QIAGEN) 
In the QIAGEN protocol, the mass of the gel slice was determined by adding the gel to a 
microcentrifuge tube of a mass previously determined using an analytical balance and 
subtracting this mass from the total mass with the gel slice.  To this tube, 3 volumes of Buffer 
QG were added, assuming a density of 1 g/mL.  The gel and binding buffer were incubated at 50 
°C for 10 minutes until the gel was completely melted, vortexing every 2 minutes.  Once the gel 
was completely dissolved, its color was checked.  A yellow solution indicated that the procedure 
could proceed but an orange or violet solution indicated the need for pH adjustment.  In this 
scenario, 10 µL of 3 M sodium acetate was added to adjust the pH.  Following this, if the size of 
the desired DNA was less than 500 bp or greater than 4000 bp, which was only the case for 
pFLAG-MAC which is 5071 bp, one gel volume of isopropanol was added and mixed.  A 
QIAquick spin column was inserted into a 2 mL collection tube, and up to 800 µL of melted gel 
was transferred to the spin column.  The column was placed in the centrifuge at 13,000 x g for 1 
minute, and the resulting filtrate was discarded.  At this point, if additional melted gel was to be 
added for a higher concentration of DNA, it would be pipetted in and placed back into the 
centrifuge under the same parameters.  A volume of 750 µL of Buffer PE, diluted with absolute 
EtOH, was added to remove residual salts and was placed into the centrifuge at 13,000 x g for 1 
minute.  The filtrate was discarded and the column and collection tube were placed back into the 
centrifuge at 13,000 x g for 2 minutes to completely dry the column.  The dry column was 
transferred to a clean, sterile 1.5 mL microcentrifuge tube and 30 µL of Buffer EB was added 
and was allowed to sit for 2 minutes.  The DNA was eluted by centrifugation at 13,000 x g for 1 
minute and the DNA was stored in the refrigerator. 
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Cycle Pure Kit 
 After a single digestion of EcoRI or HindIII, the Cycle Pure Kit can be used to stop the 
previous digestion, wash the DNA, and prepare for the next digestion.  This step can also be used 
after PCR to wash the DNA.  To each microcentrifuge tube, five volumes of CP Buffer (500 µL 
based on the volume of the PCR reactions) were added and vortexed thoroughly.  The mixtures 
were briefly centrifuged to collect all material from the lids, and the contents of each tube were 
transferred to a HiBind DNA Minicolumn placed in a 2 mL collection tube.  Each column was 
placed in the centrifuge for 1 minute at 13,000 x g, and the flow through was discarded.  A 
volume of 700 µL of Wash Buffer (diluted with absolute ethanol) was added, and each tube was 
placed in the centrifuge for 1 minute at 13,000 x g.  After discarding the flow through, an 
additional 700 µL of Wash Buffer was added.  Each tube was placed in the centrifuge for 1 
minute at 13,000 x g, and the flow through was discarded.  The column was placed back into the 
centrifuge for 2 minutes at 13,000 x g to completely remove any residual ethanol.  The dry 
columns were transferred a clean 1.5 mL microcentrifuge tube, and 20 µL of Elution Buffer were 
added directly to each filter.  After sitting for two minutes, the DNA was eluted by centrifugation 
at 13,000 x g for 1 minute.  At this point, DNA was stored in the refrigerator to await a second 
digestion.  The second digestion was halted by running the digested products through an agarose 
gel and then extracted as was described earlier. 
Enzymatic Digestion 
 Upon the successful extraction of EGFP and β-lactamase PCR products from the agarose 
gel, each of these, along with the pFLAG-MAC vector that is seen in Figure 14, were 
sequentially digested with EcoRI and HindIII.  For each digestion procedure, the following were 
added to a 1.5 mL microcentrifuge tube for EGFP, β-lactamase, and pFLAG-MAC individually: 
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25.5 µL DNA, 3.0 µL of digestion buffer H for EcoRI reactions and 3.0 µL of digestion buffer M 
for HindIII reactions, and 1.5 µL of either EcoRI or HindIII.  Each tube was allowed to sit in a 37 
°C warm water bath for 3 hours as digestion of the DNA completed.  Between EcoRI and 
HindIII digestions, the previous digestion procedure was halted by using the Cycle Pure Kit. 
Figure 14: Plasmid map of pFLAG-MAC 
NanoDrop 
 The NanoDrop is an instrument used to measure the concentration of the DNA after the 
completions of many different protocols, and the protocol for this instrument follows: to first 
clean the NanoDrop lens and lens table, 3 µL of ultrapure deionized water was pipetted onto the 
NanoDrop lens table. The lid was closed and allowed to sit for 2-3 minutes, and the water was 
then dabbed off both the lens and the lens table with a Kimwipe.  Afterward, the arm was gently 
lowered back down, and the NanoDrop 2000c UV-Vis Spectrophotometer software was initiated.  
The Nucleic Acid program was selected and the program was allowed to proceed with 
wavelength verification.  A volume of 2 µL of elution buffer was pipetted onto the lens table, the 
lid was closed and the sample was blanked.  To confirm the reliability of the blank, the previous 
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blank sample was dabbed off and a new blank sample was measured to check if the 
concentration was recording at 0.0 ng/ µL.  This was dabbed off with a Kimwipe and 2 µL of the 
DNA sample in elution buffer was added to the lens table and the “Measure” button was 
activated.  This protocol was repeated between successive samples, and the instrument was 
blanked again every 2-3 measurements.  The concentration of each sample was recorded along 
with the 260/280 and 260/230 wavelength ratio.  After all samples had been measured, the lens 
table was cleaned with an additional  3 µL of ultrapure deionized water, allowed to sit for 2-3 
minutes, and gently dabbed of with a dry Kimwipe. 
LB Agar Plates with Ampicillin 
 LB Agar plates containing ampicillin were created for use during transformations.  A 
volume of 400 mL of deionized water was added to a 1 L buffer bottle along with 14 g of LB 
agar powder and was capped with a foil lid.  This mixture was placed in an autoclave bucket was 
autoclaved for 20 minutes at 121 °C on a liquid setting.  Once the autoclave had cooled, the flask 
was removed and allowed to continue to cool until it reached about 50°C.  At this point, 0.040 g 
ampicillin was added to create a 100 µg/mL solution.  A volume of 20 mL of the cooled agar was 
poured into each of 20 sterile petri dishes.  These were allowed to cool and were stored agar side 
up in the refrigerator for later use. 
Transformation 
In order to generate new stocks of pEGFP and pFLAG-MAC, old DNA minipreps of each 
were transformed into DH5α E.coli cells.  To accomplish this, competent DH5α cells (stored at -
80 °C) were thawed on ice alongside two 14 mL polypropylene BD Falcon tubes, which were 
being chilled.  The thawed cells were gently mixed and were added to the Falcon tubes in 100 µL 
aliquots.  The pEGFP and pFLAG-MAC minipreps were added to their own tube and the cells 
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were incubated on ice for 30 minutes.  After this, the cells were heat shocked for 45 seconds in a 
42 °C water bath and were placed back on ice for 2 minutes.  To this mixture, 900 µL of room 
temperature S.O.C. Medium was added, and the Falcon tubes were placed on the shaker table for 
1 hour at 37 °C and 225 rpm.  A volume of 20 µL of this mixture was spread over LB agar plates 
made with 100 µg/mL ampicillin.  The plates were incubated overnight at 37 °C.  Growth was 
observed the next day and the cells containing pEGFP were observed glowing under UV light.  
These plates were stored in the refrigerator. 
In order to complete the process of making new stocks, isolated colonies were picked from 
the fresh plates and were grown in overnight culture.  A volume of 1.5mL of culture was added 
to a cryogenic vial and diluted with and 0.5mL of 100% sterile glycerol.  The 75:25 mixture of 
cells was shaken thoroughly and was placed in the -80°C freezer to serve as stocks for future 
overnight cultures of pEGFP and pFLAG-MAC. 
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Results and Discussion 
Generation of New Stocks 
 Concentrations of DNA have been consistently low throughout all portions of this 
research.  Throughout this work, different attempts were made to try to increase these 
concentrations by optimizing protocols of all parts of this experiment so that concentrations of 
DNA can remain high enough to complete the validation of the local pH theory.  In order to 
increase DNA concentrations, one method utilized was to generate new stocks from which 
overnight cultures could be grown.  An old miniprep of pEGFP template DNA from previous 
years was transformed using the DHH5α cells, and these cells glowed green and on ampicillin 
containing agar, seen in Figure 15.  Accordingly, it was confirmed that the cells on the plates 
contained the pEGFP plasmid, and all of the protocols were performed using this new set of 
cells. 
 
Figure 15: Colonies of DH5α E.coli cells containing pEGFP glowing green under UV Light  
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 Using the miniprep generated from the new stocks, PCR reactions were run and separated 
in an agarose gel not only to separate the genes of interest from primer dimers and other DNA, 
but to confirm that the genes of interest were indeed present in the gels at around 800 bp, seen in 
Figure 16.  The band that is fourth from the bottom on the 1kb ladder marks 700 bp and the band 
that is fifth from the bottom marks 1000 bp.  Because the bands from the PCR products are 
between these two reference bands, but closer to the 700 bp band, it can be validated that the 
genes of interest are at around 800 bp.  However, these bands of both EGFP and β-lactamase 
were faint, and primer dimer bands at the end of the gel were still fairly bright.  In an attempt to 
increase the concentration of the DNA found here without starting over, the gel was extracted 
and run through an additional round of PCR in an attempt to increase DNA concentrations, but 
all DNA was lost, as seen in Figure 17. 
 
Figure 16: Faint bands of DNA present using new stocks 
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Figure 17: Gel after second round of DNA amplification 
In order to determine at what stage DNA was being lost, the concentration of leftover 
DNA from before the second amplification procedure was checked using the NanoDrop and was 
found to be 0.0 ng/µL for both β-Lactamase and EGFP.  Accordingly, it was suspected that a 
great deal of the DNA could have been lost during the gel extraction procedure.  Using the same 
miniprep, PCR was performed at a higher annealing temperature, 67.0 °C instead of 65.0 °C, and 
a gel was run using wider wells.  This gel exhibited much brighter bands of DNA, seen in Figure 
18.  The concentration of the extracts of these bands can be seen in Table 8. 
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Figure 18: Separation of PCR products through gel electrophoresis 
 
Table 8: Concentrations of β-lactamase and EGFP after amplification of new stocks 
 Concentration (ng/µL) 
β-Lactamase 30.6 
EGFP 19.1 
 
The DNA from these brighter bands was sequentially digested once with EcoRI and then 
again with HindIII, and another gel was run to stop the second digestion.  This gel showed faint 
bands for EGFP and β-lactamase and a bright band for pFLAG-MAC that had been extracted 
from a previous gel and was digested alongside the other samples, seen in Figure 19.  The 
concentrations of β-lactamase and EGFP, after the first and second digestions and the 
concentration of and pFLAG-MAC after the second digestion can be seen in Table 9.  
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Figure 19: Post digestion products for β-lactamase, EGFP, and pFLAG-MAC 
 
Table 9: Concentrations of digestion products after first, EcoRI, and second, HindIII, digestions 
 Concentration (ng/µL) 
β-Lactamase (First Digestion) 24.3 
EGFP (First Digestion) 13.6 
β-Lactamase (Second Digestion) 1.4 
EGFP (Second Digestion) 0.0 
pFLAG-MAC (Second Digestion) 20.8 
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Since concentrations of EGFP and β-Lactamase had become absent or negligible, a new 
PCR reaction was set up using the same miniprep generated from the new stocks and run through 
a gel, seen in Figure 20.  However, only the β-lactamase band was present in this gel. 
 
Figure 20: Gel after new PCR with no EGFP band present 
In an attempt to obtain an EGFP sample to digest alongside the existing β-Lactamse 
sample, an attempt was made to isolate EGFP alone.  Using the same miniprep for another round 
of PCR amplification, another gel was run using two lanes of EGFP PCR products since none 
was present in the previous run, seen in Figure 21. 
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Figure 21: Gel of EGFP bands 
Optimization of Gel Extraction Parameters 
The bands of EGFP generated in the Figure 21 were very faint, so in an attempt to 
increase DNA concentrations further before proceeding, another PCR procedure was completed 
so that multiple slices of gel were added at once to the HiBind DNA Minicolumn during the gel 
extraction procedure.  This additional set of PCR products to be used for this modified gel 
extraction protocol can be seen in Figure 22. 
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Figure 22: Gel of β-lactamase and EGFP 
These gel slices, from Figure 20, Figure 21, and Figure 22, were all extracted together.  
The concentrations of this extraction can be seen in Table 10.  However, the concentration of the 
DNA was still lower than would be preferred, specifically for EGFP.  In order to determine if 
some of the DNA was being left in the column during gel extraction and test this procedure as a 
possible source of DNA loss, a second elution was performed on the columns. 
Table 10: Concentrations of β-lactamase and EGFP after one and two elutions after gel 
extraction 
 Concentration (ng/µL) 
β-Lactamase (First Elution) 49.4 
EGFP (First Elution) 10.2 
β-Lactamase (Second Elution) 0.3 
EGFP (Second Elution) 0.9 
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Accordingly, it was determined that the majority of the DNA was being eluted from the 
columns, and the loss of DNA must be occurring elsewhere.  Accordingly, four more gels, each 
containing β-lactamase and EGFP PCR products were run to see if increasing the amount of 
DNA containing agarose by this amount would provide a large enough quantity of DNA to make 
it through the digestion, ligation, and transformation procedures.  Two of the gels showed only 
bands only for β-lactamase, seen in Figure 23, and two other gels showed bands for both β-
lactamase and EGFP.   
 
Figure 23: Gel Displaying Only the Band for β-lactamase 
In order to determine if the OMEGA Gel Extraction Kit was the cause of the DNA loss, 
two of the β-lactamase gel slices were extracted through a single column using the OMEGA 
protocol and the other two β-lactamase gel slices were extracted through a single column using 
the QIAGEN protocol.  Since fewer bands containing EGFP had been acquired from the gels, it 
was only extracted using the QIAGEN protocol in hopes that it would produce better yields.  The 
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concentrations seen in Table 11 were recorded.  In light of doubled concentrations of DNA using 
the QIAGEN protocol compared to the OMEGA protocol, the QIAGEN kit was used for all 
subsequent gel extractions. 
Table 11: Concentrations of β-Lactamase and EGFP after gel extraction with OMEGA and 
QIAGEN kits 
 Concentration (ng/µL) 
β-Lactamase (OMEGA) 14.9 
β-Lactamase (QIAGEN) 28.7 
EGFP (QIAGEN) 11.1 
 
Optimization of PCR Parameters 
Since only β-lactamase gel extracts had been formed at high enough concentrations to 
proceed with digestion, another PCR of only EGFP was set up with new miniprep made from 
new overnight cultures.  The EGFP PCR products were run through a gel, seen in Figure 24.  
Though the bands were faint, they were put together and extracted using the QIAGEN protocol, 
but this extract was found to only have a concentration of 6.1 ng/µL. 
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Figure 24: Gel of only EGFP PCR products 
As it had now become clear that there must be some other source of the reduction of 
DNA concentration other than the gel extraction procedure, a plan was developed for the 
optimization of the PCR protocol.  Furthermore, since DNA concentrations had become far too 
low to proceed with subsequent steps, a new adjusted PCR protocol was developed that would 
use a much greater concentration of template DNA, 10 µL instead of 4 µL.  After a PCR of only 
EGFP was run under these parameters, another gel was run, seen Figure 25.  No DNA was 
present in this gel, and even the brightness of the primer dimers was decreased.  It is 
hypothesized that the increased salt concentration coming from the increase in elution buffer 
containing the template DNA prevented the Taq polymerase from functioning.  Accordingly, this 
procedure was not used again and the volumes of PCR components were adjusted back. 
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Figure 25: Gel of only EGFP with no PCR products present after increasing template DNA 
concentration 
In a new attempt to increase concentrations of DNA during PCR, the PCR protocol was 
completely changed.  The enzyme Pfu Turbo was used in place of Taq polymerase and MgCl2, 
and template DNA concentrations changed back to previous concentrations to further decrease 
salt concentrations and hopefully increase enzyme activity.  The annealing temperature was also 
further decreased to a temperature optimum for this new enzyme, and the order of the addition of 
the reactants was adjusted.  A PCR reaction was set up for using the new Pfu Turbo protocol, but 
it was not successful and no bands were visible except for primer dimers, as seen in Figure 26.  
However, at this point, the failed reactions were probably due to a loss of DNA in the miniprep 
rather than a failure of the Pfu Turbo polymerase. 
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Figure 26: Gel run with β-lactamase and EGFP with no PCR products present after using the Pfu 
Turbo protocol 
 
In an attempt to re-evaluate the failed PCR reaction visualized in the previous figure 
using the Pfu Turbo PCR protocol, the annealing temperature was increased back to 67 °C for 50 
cycles to come closer to the melting temperatures of the primers. However, the gel run of these 
products showed that the PCR reaction was again unsuccessful, as seen in Figure 27.  
 
Figure 27: Gel run with β-lactamase and EGFP with no PCR products present after altering the 
Pfu Turbo protocol to a higher annealing temperature 
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 Accordingly, another gel was run using the Taq polymerase protocol to see if the Pfu 
Turbo was the source of the errors, and the gel seen in Figure 28 shows the results.  This reaction 
was also not successful.  Accordingly, it could not be determined what was causing the loss of 
DNA at this point.  
 
 
Figure 28: Gel run with β-lactamase and EGFP with no PCR products present after checking 
Taq polymerase protocol against the Pfu Turbo protocol  
 
It was hypothesized that PCR was unsuccessful because the template DNA being used 
was too low in concentration to begin with.  So, in an attempt to create higher concentration 
minipreps from the new stocks, overnight cultures were started of pEGFP and pFLAG-MAC and 
were allowed to grow in the incubator for only 15 hours to prevent overgrowth as a possible 
source of low miniprep concentration.  These cultures were miniprepped according to the 
OMEGA protocol, and were found using the NanoDrop to have the concentrations seen in Table 
12.  The concentrations were all lower than expected and the unusual wavelength ratios of 
260/280 and 260/230 seemed to indicate an imprecision with blanking of the NanoDrop.  
Afterwards, the NanoDrop was found to measure the blank anywhere from -0.6 ng/µL to 0.8 
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ng/µL, but never 0.0 ng/µL.  A desirable range of the 260/280 wavelength ratios to demonstrate 
sample purity would be between 1.80-2.00, and a desirable range for the 260/230 ratios would be 
between 2.00-2.20.  Accordingly, the wavelength ratios could not properly be analyzed to assess 
the purity of the samples. 
 
Table 12: Concentration of pEGFP minipreps prior to PCR 
 
Concentration (ng/µL) 260/280 260/230 
pEGFP1 26.3 2.00 2.42 
pEGFP2 25.4 2.11 14.03 
pEGFP3 11.0 2.33 -3.03 
pEGFP4 33.9 2.15 5.39 
pEGFP5 17.7 2.22 285.34 
pEGFP6 15.9 2.33 -14.31 
 
As none of these miniprep concentrations were as high as was desirable, it was 
hypothesized that the freezing of the cells in the -80 °C freezer was reducing viability, 
particularly if the power to the freezer had ever gone out and the cells had undergone a thawing 
and refreezing process.  Accordingly, a sample of previously isolated template DNA was used 
for a transformation procedure into DH5α cells so that cultures could be grown from never 
frozen cells.  To see if the freezing of the cells was reducing viability, a transformation was set 
up of a sample of the template DNA that had been used for previous reactions, rather than from 
stocks stored in the -80 °C freezer.  However, the transformation of pEGFP (on the left) was 
unsuccessful, but there was growth on pUC 19 control plasmid (on the right) was successful, 
seen in Figure 29.  The lack of growth of pEGFP but the growth of the positive control showed 
that the transformation procedure was good, but the pEGFP plasmid was not present in the 
sample. 
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Figure 29: a) Transformation of the pEGFP b) Transformation of pUC 19 control 
 
Since the miniprep tested appeared devoid of the desired DNA, overnight cultures were 
grown from colonies expressing pEGFP that were picked off a plate from a previous 
transformation procedure.  Then, all 6 cultures were miniprepped using the QIAGEN kit and 
their concentrations were checked using the NanoDrop to produce the concentrations seen in 
Table 13.  The sample pEGFP1 was set aside in case a need arose for another transformation 
procedure. 
 
Table 13: Concentration of pEGFP after miniprep from previously transformed DH5α cells 
 Concentration (ng/µL) 260/280 260/230 
pEGFP1 36.3 1.92 2.22 
pEGFP2 7.6 2.08 3.60 
pEGFP3 13.8 2.02 3.04 
pEGFP4 4.5 2.58 -5.23 
pEGFP5 41.3 1.94 2.35 
pEGFP6 23.0 2.04 2.65 
b a 
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 A new PCR reaction was set up using the standard protocol with the new miniprep of 
highest concentration along with a new stock of Taq polymerase.  The PCR products from this 
reaction were run through a gel, seen in Figure 30. 
 
 
Figure 30: Gel of β-lactamse and EGFP using new miniprep and new Taq polymerase 
 
 Given the success of this gel, that same miniprep was used as template DNA for a set of 
PCR reactions at six different annealing temperatures in the gradient thermocycler to optimize 
the amplification of both genes.  The reactant volume had to be adjusted to 40 µL per PCR tube 
and one sample each for β-lactamse and EGFP were at annealing temperatures of 50.0 °C, 54.0 
°C, 58.0 °C, 62.0 °C, 66.0 °C, and 70.0 °C.  The products of this reaction were run on two 
separate gels in order of increasing annealing temperature, seen in Figure 31.  
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Figure 31: a) Gradient PCR Products of EGFP b) Gradient PCR Products of β-lactamase 
 
The bands on the EGFP gel appear to be between 2000-2500 bp in size, so this is not 
EGFP.  Potentially, this could have been due to the addition of the wrong set of primers.  The 
bands on the gel of β-lactamase appear to be about 800 bp in size, the appropriate size for β-
lactamase.  Accordingly, a new gradient PCR was set up under the same parameters using only 
EGFP and were run through the gel in order of increasing annealing temperature, seen in Figure 
32.  Between, Figure 31 and Figure 32, the band at 58.0 °C appears to be the brightest for EGFP 
DNA and the temperature range of 62-70 °C appears to be the brightest for β-lactamase DNA, so 
subsequent PCR reactions were run at these temperatures. 
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Figure 32: Gradient PCR Products of EGFP 
Optimization of Miniprep Parameters 
 Due to the success of changing from an OMEGA gel extraction kit to a QIAGEN gel 
extraction kit, a QIAGEN miniprep kit was used to create a new set of pEGFP miniprep.  The 
concentration of these minipreps, which can be seen in Table 14, are roughly five times the 
concentrations of miniprep DNA produced by the OMEGA kits.  Furthermore, both the 260/280 
and the 260/230 wavelength ratios are at reasonable values of around 2.00, indicating that the 
NanoDrop was functioning properly when these concentrations were determined and the samples 
were uncontaminated.  It was concluded after these findings that the QIAGEN kit would be used 
for any subsequent miniprep procedures. 
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Table 14: Miniprep concentrations after using QIAGEN miniprep kit 
 Concentration (ng/µL) 260/280 260/230 
pEGFP1 141.9 1.97 1.96 
pEGFP2 154.7 1.98 2.11 
pEGFP3 148.6 1.98 2.16 
pEGFP4 111.5 2.02 2.25 
pEGFP5 128.7 1.99 2.16 
pEGFP6 150.7 1.96 2.00 
 
Validation of the Local pH Theory 
 Since the optimization of PCR parameters, gel extraction protocols, and other procedures 
were completed, work on this project was focused on completing the validation of the local pH 
theory by utilizing the ability to generate higher concentrations of DNA.  A gel extraction 
procedure was completed using the QIAGEN kit on the gels slices from the gradient PCR, 
though the larger gel volume for β-lactamase necessitated that it be split into two separate 
extraction columns.  The concentrations of these extracts were determined using the NanoDrop, 
seen in Table 15. 
Table 15: Concentration of EGFP and Β-Lactamase after protocol optimization 
 Concentration (ng/µL) 
EGFP 23.4 
β-Lactamase1 53.4 
β-Lactamase2 33.2 
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These extracts, along with previously amplified DNA and pFLAG-MAC miniprep were 
sequentially digested with EcoRI and HindIII.  The gel that stopped the second digestion can be 
seen in Figure 33.  Bright bands of digested DNA for β-Lactamse, EGFP, and the expression 
vector pFLAG-MAC were all present, so these bands were cut out to be extracted and ligated to 
complete the recombinant vectors that will be transformed to finish the molecular cloning stages 
of the validation of the local pH theory. 
 
 
 
 
 
 
 
 
 
Figure 33: Gel of digestion PCR products after annealing temperature optimization  
	  
	  
63 
	  
Conclusions and Future Work 
 The major goal of this work was to optimize the parameters for the completion of the 
validation of the local pH theory so that a sensing system can be created to measure the 
hydrolysis of β-lactam antibiotics.  Accordingly, new pEGFP stocks were generated and it was 
determined that pEGFP was lost in them.  The plasmid pEGFP was isolated from other cultures 
and the gel extraction procedure was optimized, and the QIAGEN kit was found to be more 
effective.  The QIAGEN kit was also found to be more effective for miniprep procedures.  A 
comparison of annealing temperatures through gradient PCR determined that the optimum 
annealing temperature for this reaction was 58 °C for EGFP and 62-70 °C for β-lactamase. 
Future work on this project will be centered using the optimized PCR, gel extraction, and 
miniprep parameters completed through this work to generate DNA at higher concentrations.  
This higher concentration DNA will be digested, ligated, and transformed in DH5α cells so that 
EGFP and β-lactamse can be expressed and purified to move towards the completion of the 
validation of the local pH theory.  Once this is completed, the fusion protein for the in vivo 
system can be both generated and expressed, so that kinetic studies on it can be completed. 
Once the development of the sensing system has been finished, it will be able to be used 
to measure the hydrolysis of β-lactam antibiotics.  Accordingly, it will also be able to be used to 
pursue and find new β-lactamase inhibitors to be used in conjunction with existing β-lactam 
antibiotics.  Furthermore, the completion of this system will allow for the monitoring of 
bioavailability of β-lactam antibiotics. 
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